[Clinical use of vitamin K-1 in hearing disorders caused by kanamycin].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D006311:Hearing Disorders / Q000139:chemically induced* / Q000188:drug therapy*; D006801:Humans; D007612:Kanamycin / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010837:Vitamin K 1 / Q000378:metabolism* / Q000627:therapeutic use*
D007612:Kanamycin; D010837:Vitamin K 1